Aberdare Management Company, LLC 3
3 · Kezar Life Sciences, Inc. · Filed Jun 20, 2018
Insider Transaction Report
Form 3
Aberdare Management Company, LLC
10% Owner
Holdings
Series A Convertible Preferred Stock
→ Common Stock (105,162 underlying)Series B Convertible Preferred Stock
→ Common Stock (31,481 underlying)
Footnotes (2)
- [F1]Each share of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock is convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, has no expiration date and will convert into shares of Common Stock upon the closing of the Issuer's initial public offering.
- [F2]The members of Aberdare Management Company, LLC are Paul H. Klingenstein and Kathleen R. Bole.